80 related articles for article (PubMed ID: 9590798)
1. [The relationship between prognosis of esophageal squamous carcinoma and Langerhans cell].
Hou W; Liu K; Qu J
Zhonghua Wai Ke Za Zhi; 1996 Jul; 34(7):430-2. PubMed ID: 9590798
[TBL] [Abstract][Full Text] [Related]
2. [Langerhans cells do not influence the postoperative survival of esophageal epidermoid carcinoma].
Rodríguez Sanjuán JC; Val-Bernal F; Buelta Carrillo L; García-Castrillo Riesgo L
Rev Esp Enferm Dig; 1993 Sep; 84(3):143-7. PubMed ID: 8217378
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells in nasopharyngeal carcinoma in relation to prognosis.
Ma CX; Jia TC; Li XR; Zhand ZF; Yiao CB
In Vivo; 1995; 9(3):225-9. PubMed ID: 8562888
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
[TBL] [Abstract][Full Text] [Related]
5. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
6. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment.
Dabrowski A; Skoczylas T; Ciechański A; Wallner G; Zinkiewicz K; Cwik G; Górczyński R; Borowski A
Med Sci Monit; 2006 Oct; 12(10):CR409-15. PubMed ID: 17006399
[TBL] [Abstract][Full Text] [Related]
7. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
8. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
10. [Langerhans cells in laryngeal carcinoma in relation to prognosis].
Zhang SR
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(5):297-8, 319. PubMed ID: 1301767
[TBL] [Abstract][Full Text] [Related]
11. Does the TNM staging system for esophageal cancer need revision?
Pramesh CS; Mistry RC; Jambhekar NA; Laskar SG
J Am Coll Surg; 2006 May; 202(5):855-6; author reply 856. PubMed ID: 16648030
[No Abstract] [Full Text] [Related]
12. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
13. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
14. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
15. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ten-year survival after operation for upper- and mid-thoracic esophageal cancer.
Kinoshita Y; Endo M; Nakayama K; Sato H; Sato H
Int Adv Surg Oncol; 1978; 1():173-200. PubMed ID: 553036
[TBL] [Abstract][Full Text] [Related]
17. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
18. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
19. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
